Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:51:32.691Z.
Calculation as of: 2026-10-06T15:51:32.691Z.
Quote observation: 2026-10-06T15:50:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e02887d9f7d553dead588493e3d1cc1cda6164751857f77264c258b40fe63259
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-07-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Fulcrum Therapeutics, Inc.
Market Cap
$283.92M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$283.42M
Price/FCF Ratio
N/A
TTM Avg
2.52
3Y Avg
2.52
5Y Avg
2.52
Market Cap
$288.87M
Price/FCF Ratio
N/A
TTM Avg
39.34
3Y Avg
39.34
5Y Avg
39.34
Market Cap
$290.91M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$276.26M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$269.13M
Price/FCF Ratio
N/A
TTM Avg
61.29
3Y Avg
61.29
5Y Avg
61.29
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | $283.92M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $283.42M | N/A | 2.52 | 2.52 | 2.52 |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.87M | N/A | 39.34 | 39.34 | 39.34 |
| Fate Therapeutics, Inc. (FATE)vs › | $279.16M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.91M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.74M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $276.26M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $269.13M | N/A | 61.29 | 61.29 | 61.29 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2025-07-29 | 62.74 |
| 2025-07-28 | 64.55 |
| 2025-07-25 | 64.55 |
| 2025-07-24 | 64.64 |
| 2025-07-23 | 65.38 |
| 2025-07-22 | 58.27 |
| 2025-07-21 | 58.69 |
| 2025-07-18 | 63.23 |
| 2025-07-17 | 65.63 |
| 2025-07-16 | 65.13 |
| 2025-07-15 | 64.80 |
| 2025-07-14 | 65.30 |
| 2025-07-11 | 64.72 |
| 2025-07-10 | 66.21 |
| 2025-07-09 | 65.38 |
| 2025-07-08 | 64.88 |
| 2025-07-07 | 58.02 |
| 2025-07-03 | 57.20 |
| 2025-07-02 | 57.28 |
| 2025-07-01 | 56.54 |
| 2025-06-30 | 56.87 |
| 2025-06-27 | 58.69 |
| 2025-06-26 | 61.00 |
| 2025-06-25 | 59.18 |
| 2025-06-24 | 59.43 |
| 2025-06-23 | 59.26 |
| 2025-06-20 | 57.86 |
| 2025-06-18 | 52.57 |
| 2025-06-17 | 53.15 |
| 2025-06-16 | 56.21 |
| 2025-06-13 | 56.62 |
| 2025-06-12 | 56.04 |
| 2025-06-11 | 56.45 |
| 2025-06-10 | 57.03 |
| 2025-06-09 | 58.85 |
| 2025-06-06 | 59.92 |
| 2025-06-05 | 58.77 |
| 2025-06-04 | 58.11 |
| 2025-06-03 | 58.19 |
| 2025-06-02 | 57.53 |
| 2025-05-30 | 56.87 |
| 2025-05-29 | 58.44 |
| 2025-05-28 | 57.03 |
| 2025-05-27 | 52.49 |
| 2025-05-23 | 53.23 |
| 2025-05-22 | 50.58 |
| 2025-05-21 | 51.66 |
| 2025-05-20 | 53.81 |
| 2025-05-19 | 57.28 |
| 2025-05-16 | 56.87 |
| 2025-05-15 | 54.55 |
| 2025-05-14 | 46.53 |
| 2025-05-13 | 47.86 |
| 2025-05-12 | 46.95 |
| 2025-05-09 | 44.39 |
| 2025-05-08 | 44.72 |
| 2025-05-07 | 41.91 |
| 2025-05-06 | 44.22 |
| 2025-05-05 | 47.36 |
| 2025-05-02 | 46.45 |
